INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

19,342 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
32
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$911K
2,300 sh
Jan 22, 2026Jan 26, 2026
Page 361 of 484
← PrevNext →
traded Jan 22, 2026
+4d
SEC Form 4

Evidence

32
SC
Schwab-Pomerantz CarolynDirector
SCHWSCHWAB CHARLES CORP
Open-market sale
SELL$500K
4,765 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

32
WA
Wilson Kelli AnnEVP Chief Banking Officer
HFWAHERITAGE FINANCIAL CORP /WA/
Open-market sale
SELL$50K
1,900 sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

30
TR
Taub RebeccaDirector
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale
SELL$319K
647 sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

29
BH
Beckwith Van H.EVP, Secretary and CLO
HALHALLIBURTON CO
Open-market sale · 10b5-1 plan
SELL$1.90M
54.3K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

27
OP
O'Day Daniel PatrickDirector, Chairman & CEO
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$15.61M
115.6K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

25
HC
Huntsman CaroleChief Commercial Officer
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$282K
570 sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

23
UJ
Unruch JoelGeneral Counsel/Corp Secretary
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$60K
214 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

23
UJ
Unruch JoelGeneral Counsel/Corp Secretary
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$172K
610 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

22
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$228K
5,000 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

21
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.64M
632.9K sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

21
UM
Urist MarshallEVP, Research & Investments
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$805K
20.0K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

20
UJ
Unruch JoelGeneral Counsel/Corp Secretary
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$39K
138 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

20
UJ
Unruch JoelGeneral Counsel/Corp Secretary
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$18K
64 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

19
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$742K
3,487 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

19
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$548K
2,600 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

19
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$278K
1,300 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

19
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$447K
2,083 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

19
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$918K
4,330 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

18
HC
Huntsman CaroleChief Commercial Officer
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$167K
340 sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

16
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.70M
632.9K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

16
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.71M
632.9K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

15
KN
Kroeker NathanCCO and Interim CFO
EOSEEos Energy Enterprises, Inc.
Open-market sale · 10b5-1 plan
SELL$802K
50.0K sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

13
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$43K
200 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

12
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$788K
5,744 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

12
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$674K
5,024 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

12
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$543K
3,928 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

12
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$843K
6,239 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

12
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$686K
5,038 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$186K
1,400 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$71K
500 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$376K
2,862 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

9
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$97K
700 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
CR
Cohlhepp RyanDirector, President and COO
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$69K
3,828 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$471K
3,604 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

9
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$376K
2,861 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

9
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$98K
700 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$60K
427 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

9
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$471K
3,603 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

8
KA
Kussell William ADirector
FWRGFirst Watch Restaurant Group, Inc.
Open-market sale · 10b5-1 plan
SELL$105K
6,165 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence